Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI)
Open Access
- 1 October 1992
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 90 (1) , 6-12
- https://doi.org/10.1111/j.1365-2249.1992.tb05823.x
Abstract
A characteristic feature associated with HIV-1 infection of the human host is a chronic decline in circulating CD4+ T helper/inducer cell numbers. Impaired cell-mediated immune functions usually occur in parallel with the decline in CD4+ T cells. Activated CD4+ T helper cells are a major source of endogenous IL-2 which is required for the immunoregulation of both antigen-specific B cells and CD8+ T cells. HIV-specific T cell proliferative responses are said to be weak and inconsistent, even during the asymptomatic phase of disease. We thus wished to determine how exogenous IL-2 affected HIV-specific T cell proliferation at different stages of the disease. Our cohort of 81 included both asymptomatic and symptomatic HIV-infected patients as well as uninfected normal donors. Proliferative responses of peripheral blood mononuclear cells (PBMC) that were elicited during culture with an immunodominant gp41-derived synthetic peptide, gp41 (8), and which were known to be CD8+ cell-associated in asymptomatics only, were used to analyse the effects of exogenous IL-2. IL-2 had three main effects on HIV-specific proliferation, namely (i) an additive effect, (ii) a synergistic effect, and (iii) an induced effect. More specifically, low dose exogenous IL-2 frequently augmented lymphoproliferation in both asymptomatic and symptomatic gp4l(8) rcspondcrs. In most symptomatics, however, who were predominantly gp4l(8) non-responders, exogenous IL-2 induced lymphoproliferation. Flow cytometric analyses using dual immunofluorescence were used to analyse the T cell subset distribution of proliferating PBMC cultures. During culture with gp4l(8), bothCD4+and CD8+ T cell numbers increased. However, after the addition of exogenous IL-2 to gp4l(8)-containing cultures, CD8+ cell-associated lymphoproliferative responses were preferentially augmented. These results suggest that in symptomatics there is an inadequate supply of endogenous IL-2 to help maintain the strong and effective CD8+ cell-associated anti-viral immunity, and an exogenous supply of IL-2 may be required.Keywords
This publication has 29 references indexed in Scilit:
- Autologous Red Cell Agglutination Assay for HIV-1 Antibodies: Simplified Test with Whole BloodScience, 1988
- CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALSThe Lancet, 1988
- T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia virusesNature, 1986
- Study of activated T cell in manClinical Immunology and Immunopathology, 1986
- Qualitative Analysis of Immune Function in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.Journal of Clinical Investigation, 1985
- Diminished interleukin 2 production and receptor generation characterize the acquired immunodeficiency syndromeClinical Immunology and Immunopathology, 1985
- Effect of Human Recombinant Alpha-2-and Gamma-Interferon on the Growth of Human Cell Lines from Solid Tumors and Hematologic MalignanciesJournal of Interferon Research, 1985
- Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.Journal of Clinical Investigation, 1983
- Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture.Journal of Clinical Investigation, 1982